SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-20-012841
Filing Date
2020-11-05
Accepted
2020-11-05 16:07:28
Documents
14
Period of Report
2020-11-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K chrs-20201105x8k.htm   iXBRL 8-K 37580
2 EX-99.1 chrs-20201105xex99d1.htm EX-99.1 277787
3 GRAPHIC chrs-20201105xex99d1001.jpg GRAPHIC 5872
  Complete submission text file 0001558370-20-012841.txt   463430

Data Files

Seq Description Document Type Size
4 EX-101.SCH chrs-20201105.xsd EX-101.SCH 2844
5 EX-101.LAB chrs-20201105_lab.xml EX-101.LAB 16156
6 EX-101.PRE chrs-20201105_pre.xml EX-101.PRE 11457
7 EXTRACTED XBRL INSTANCE DOCUMENT chrs-20201105x8k_htm.xml XML 4909
Mailing Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065
Business Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065 (650) 649-3530
Coherus BioSciences, Inc. (Filer) CIK: 0001512762 (see all company filings)

IRS No.: 273615821 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36721 | Film No.: 201290456
SIC: 2836 Biological Products, (No Diagnostic Substances)